Amdocs Beats Q1 Expectations, But Margins Squeeze

Amdocs exceeded Wall Streets expectations in Q1 2026, with revenue up 3.9% to $1.17 billion and adjusted EPS at $1.78, surpassing estimates. However, full-year adjusted EPS guidance missed forecasts, and operating margins slipped. Despite a margin squeeze, the stock rose, and analysts project 3% revenue and 8.5% EPS growth. Amdocs must improve margins and growth to maintain momentum. Support the show:Get a discount at https://solipillow.com/discount/dnn. Advertise on DNN:[email protected] This is an automated, high-level news summary based on public reporting.Report issues to [email protected]. View sources & latest updates:https://sources.thednn.ai/e0477c73803d700b